PAREXEL chairman and CEO Josef von Rickenbach elected 2013 ACRO chairman January 10, 2013 CenterWatch Staff
European Medicines Agency to focus on efficiency, transparency in 2013 January 10, 2013 CenterWatch Staff
Tufts says drug developers need to more fully identify, address root causes of R&D inefficiency January 9, 2013 CenterWatch Staff
BIND, Amgen ink agreement for development of a kinase inhibitor nanomedicine January 9, 2013 CenterWatch Staff
Daiichi Sankyo, Amplimmune to develop AMP-110 therapy for autoimmune disease January 9, 2013 CenterWatch Staff